Yale’s Review of Advances in Oncology Highlights from the ASCO Annual Meeting 2025

Yale’s Review of Advances in Oncology: Highlights from the ASCO Annual Meeting 2025 will be held live on Friday, September 26, 2025, at the New Haven Lawn Club in New Haven, CT. This symposium will present the most impactful updates from the 2025 ASCO Annual Meeting, curated by Yale faculty to meet the educational needs of oncology professionals.

The agenda is designed to enhance understanding of emerging therapies, clinical trials, and best practices in cancer care—delivered through expert-led lectures and case-based discussions. Attendees will receive condensed, high-yield content without navigating days of sessions.

Based on the strong attendance at prior Yale Oncology CME events, we expect approximately 150 participants.

1. Describe the current treatment options and updates in various cancer modalities.
2. Discuss the development and outcomes of clinical cancer research trials and assess their relevance to patient care
3. Assess the emerging role of immunotherapy, targeted therapies, and antibodies in oncology

Cancellation Policy
Cancellations must be received in writing (email is acceptable) at least one week prior to the start of the conference to receive a refund. Requests received after this deadline or by telephone will not be honored.

Payment by Check
If paying by check, please include the conference name in the memo line. Make checks payable to Yale University and mail to:

Yale University
Center for Continuing Medical Education
c/o Anne Stark
367 Cedar Street – ESH Building A – 2nd Floor
New Haven, CT 06510-3240

For questions, contact the Yale Continuing Medical Education at?[email protected].

Accreditation Statement
The Yale School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 

Designation Statement
Yale School of Medicine approves this live activity for 6.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MOC POINTS ~ Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn 6.0 Medical Knowledge Only MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) Part II program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Disclosure Policy
It is the policy of Yale School of Medicine, Continuing Medical Education (CME), to ensure balance, independence, objectivity, and scientific rigor in all its educational programs.  All individuals involved in the development and presentation of Accredited Continuing Education activities are required to disclose all financial relationship(s) with ineligible companies that has occurred within the past 24 months; and the opportunity to affect the content of CME about the products or services of the commercial interests. This information is disclosed to all activity participants prior to the commencement of the educational activity.

Financial Statement
The Yale School of Medicine and Yale Cancer Center are grateful to their supporters. They are acknowledged in all conference materials. 

This symposium is being held at New Haven Lawn Club, located at 193 Whitney Ave, New Haven, CT 06511. Free on-site parking is available. 

Mitigation of Relevant Financial Relationships

Yale Continuing Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Friday, September 26, 2025

We thank our current exhibitors for their support!

1. Abbvie

2. Amgen, Inc.

3. AVEO Oncology

4. Bayer

5. BeiGene USA, Inc.

6. Blueprint Medicines

7. Bristol-Myers Squibb

8. Cancer Care

9. Daiichi Sankyo, Inc.

10. Eisai

11. EMD Serono

12. Exelixis

13. Foundation Medicine

14. GlaxoSmithKline

15. Incyte Corporation

16. Jazz Pharmaceuticals

17. Janssen

18. Lilly

19. Merck

20. Natera

21. Novartis

22. Novocure

23. Nuvation Bio

24. Pfizer

25. Pharmacyclics

26. PharmaEssentia

27. Puma Biotechnology

28. Regeneron

29. Rev Med

30. Sanofi

31. Springworks

32. Sunitomo Pharma

33. Takeda Oncology

34. Verastem Oncology